The problem
Regulatory submission timelines are one of the most expensive bottlenecks in pharmaceutical operations. Every week of delay in a CMC variation, market authorisation, or post-approval change prevents patient impact and delays market access.
Yet the document flow and administrative processes behind submissions are rarely examined with the same rigour applied to manufacturing or clinical operations.
Why it happens
Invisible waste in document flow
Submission processes evolve over decades. The official process bears little resemblance to what actually happens. Wait times, rework loops, and approval bottlenecks hide in plain sight.
Handoff friction between functions
Regulatory, quality, CMC, clinical, and commercial teams each own a piece of the submission. Nobody owns the handoffs. Work sits in queues while the submission clock keeps ticking.
Validated state paralysis
Teams in regulated environments resist process change because they fear compromising validated states. Inefficient workarounds persist indefinitely because “we have always done it this way.”
System under-utilisation
Organisations invest millions in platforms like Veeva Vault but use a fraction of their capability. Submission plans, workflows, and reporting replicate legacy processes rather than exploit system potential.
What I do
Investment
Track record
Ready to compress your submission timelines?
Start with a conversation about your current regulatory document flow and where time is being lost.
Book an initial conversation